The NLRP3 Inflammasome May Contribute to Pathologic Neovascularization in the Advanced Stages of Diabetic Retinopathy

Abstract Diabetic retinopathy (DR) is a retinal microvascular disease characterized by inflammatory and angiogenic pathways. In this study, we evaluated NLRP3 inflammasome in a double transgenic mouse model, Akimba (Ins2 Akita xVEGF +/−), which demonstrates hyperglycemia, vascular hyperpermeability...

Full description

Bibliographic Details
Main Authors: Shyam S. Chaurasia, Rayne R. Lim, Bhav H. Parikh, Yeo Sia Wey, Bo Bo Tun, Tien Yin Wong, Chi D. Luu, Rupesh Agrawal, Arkasubhra Ghosh, Alessandra Mortellaro, Elizabeth Rackoczy, Rajiv R. Mohan, Veluchamy A. Barathi
Format: Article
Language:English
Published: Nature Publishing Group 2018-02-01
Series:Scientific Reports
Online Access:https://doi.org/10.1038/s41598-018-21198-z
id doaj-f5819ad73a044bfe965b05e365cb38eb
record_format Article
spelling doaj-f5819ad73a044bfe965b05e365cb38eb2020-12-08T05:51:00ZengNature Publishing GroupScientific Reports2045-23222018-02-018111510.1038/s41598-018-21198-zThe NLRP3 Inflammasome May Contribute to Pathologic Neovascularization in the Advanced Stages of Diabetic RetinopathyShyam S. Chaurasia0Rayne R. Lim1Bhav H. Parikh2Yeo Sia Wey3Bo Bo Tun4Tien Yin Wong5Chi D. Luu6Rupesh Agrawal7Arkasubhra Ghosh8Alessandra Mortellaro9Elizabeth Rackoczy10Rajiv R. Mohan11Veluchamy A. Barathi12Ocular Immunology and Angiogenesis Lab, Department of Veterinary Medicine & Surgery, University of MissouriOcular Immunology and Angiogenesis Lab, Department of Veterinary Medicine & Surgery, University of MissouriTranslational Pre-Clinical Model Platform, Singapore Eye Research InstituteTranslational Pre-Clinical Model Platform, Singapore Eye Research InstituteTranslational Pre-Clinical Model Platform, Singapore Eye Research InstituteTranslational Pre-Clinical Model Platform, Singapore Eye Research InstituteCentre for Eye Research Australia, Department of Surgery (Ophthalmology), University of MelbourneNational Healthcare Group Eye Institute, Tan Tock Seng HospitalGROW laboratory, Narayana NethralayaSingapore Immunology Network (SIgN), Agency for Science, Technology and Research (A*STAR)Centre for Ophthalmology and Visual Sciences, University of Western AustraliaOcular Immunology and Angiogenesis Lab, Department of Veterinary Medicine & Surgery, University of MissouriTranslational Pre-Clinical Model Platform, Singapore Eye Research InstituteAbstract Diabetic retinopathy (DR) is a retinal microvascular disease characterized by inflammatory and angiogenic pathways. In this study, we evaluated NLRP3 inflammasome in a double transgenic mouse model, Akimba (Ins2 Akita xVEGF +/−), which demonstrates hyperglycemia, vascular hyperpermeability and neovascularization seen in the proliferative DR. Retinal structural integrity, vascular leakage and function were examined by fundus photography, fluorescein angiography, optical coherence tomography, retinal flat mounts, laser speckle flowgraphy (LSFG), and electroretinography in Akimba and its parental strains, Akita (Ins2 Akita ) and Kimba (trVEGF029) mice. Inflammatory mechanisms involving NLRP3 inflammasome were investigated using real time-PCR, immunohistochemistry, ELISA and western blots. We observed an increased vascular leakage, reduced retinal thickness, and function in Akimba retina. Also, Akimba retina depicts decreased relative flow volume measured by LSFG. Most importantly, high levels of IL-1β along with increased NLRP3, ASC, and Caspase-1 at mRNA and protein levels were observed in Akimba retina. However, the in vivo functional role remains undefined. In conclusion, increased activation of macroglia (GFAP), microglia (Iba-1 and OX-42) and perivascular macrophages (F4/80 and CD14) together with pro-inflammatory (IL-1β and IL-6) and pro-angiogenic markers (PECAM-1, ICAM-1, VEGF, Flt-1, and Flk-1), suggested a critical role for NLRP3 inflammasome in the Akimba mouse model depicting advanced stages of DR pathogenesis.https://doi.org/10.1038/s41598-018-21198-z
collection DOAJ
language English
format Article
sources DOAJ
author Shyam S. Chaurasia
Rayne R. Lim
Bhav H. Parikh
Yeo Sia Wey
Bo Bo Tun
Tien Yin Wong
Chi D. Luu
Rupesh Agrawal
Arkasubhra Ghosh
Alessandra Mortellaro
Elizabeth Rackoczy
Rajiv R. Mohan
Veluchamy A. Barathi
spellingShingle Shyam S. Chaurasia
Rayne R. Lim
Bhav H. Parikh
Yeo Sia Wey
Bo Bo Tun
Tien Yin Wong
Chi D. Luu
Rupesh Agrawal
Arkasubhra Ghosh
Alessandra Mortellaro
Elizabeth Rackoczy
Rajiv R. Mohan
Veluchamy A. Barathi
The NLRP3 Inflammasome May Contribute to Pathologic Neovascularization in the Advanced Stages of Diabetic Retinopathy
Scientific Reports
author_facet Shyam S. Chaurasia
Rayne R. Lim
Bhav H. Parikh
Yeo Sia Wey
Bo Bo Tun
Tien Yin Wong
Chi D. Luu
Rupesh Agrawal
Arkasubhra Ghosh
Alessandra Mortellaro
Elizabeth Rackoczy
Rajiv R. Mohan
Veluchamy A. Barathi
author_sort Shyam S. Chaurasia
title The NLRP3 Inflammasome May Contribute to Pathologic Neovascularization in the Advanced Stages of Diabetic Retinopathy
title_short The NLRP3 Inflammasome May Contribute to Pathologic Neovascularization in the Advanced Stages of Diabetic Retinopathy
title_full The NLRP3 Inflammasome May Contribute to Pathologic Neovascularization in the Advanced Stages of Diabetic Retinopathy
title_fullStr The NLRP3 Inflammasome May Contribute to Pathologic Neovascularization in the Advanced Stages of Diabetic Retinopathy
title_full_unstemmed The NLRP3 Inflammasome May Contribute to Pathologic Neovascularization in the Advanced Stages of Diabetic Retinopathy
title_sort nlrp3 inflammasome may contribute to pathologic neovascularization in the advanced stages of diabetic retinopathy
publisher Nature Publishing Group
series Scientific Reports
issn 2045-2322
publishDate 2018-02-01
description Abstract Diabetic retinopathy (DR) is a retinal microvascular disease characterized by inflammatory and angiogenic pathways. In this study, we evaluated NLRP3 inflammasome in a double transgenic mouse model, Akimba (Ins2 Akita xVEGF +/−), which demonstrates hyperglycemia, vascular hyperpermeability and neovascularization seen in the proliferative DR. Retinal structural integrity, vascular leakage and function were examined by fundus photography, fluorescein angiography, optical coherence tomography, retinal flat mounts, laser speckle flowgraphy (LSFG), and electroretinography in Akimba and its parental strains, Akita (Ins2 Akita ) and Kimba (trVEGF029) mice. Inflammatory mechanisms involving NLRP3 inflammasome were investigated using real time-PCR, immunohistochemistry, ELISA and western blots. We observed an increased vascular leakage, reduced retinal thickness, and function in Akimba retina. Also, Akimba retina depicts decreased relative flow volume measured by LSFG. Most importantly, high levels of IL-1β along with increased NLRP3, ASC, and Caspase-1 at mRNA and protein levels were observed in Akimba retina. However, the in vivo functional role remains undefined. In conclusion, increased activation of macroglia (GFAP), microglia (Iba-1 and OX-42) and perivascular macrophages (F4/80 and CD14) together with pro-inflammatory (IL-1β and IL-6) and pro-angiogenic markers (PECAM-1, ICAM-1, VEGF, Flt-1, and Flk-1), suggested a critical role for NLRP3 inflammasome in the Akimba mouse model depicting advanced stages of DR pathogenesis.
url https://doi.org/10.1038/s41598-018-21198-z
work_keys_str_mv AT shyamschaurasia thenlrp3inflammasomemaycontributetopathologicneovascularizationintheadvancedstagesofdiabeticretinopathy
AT raynerlim thenlrp3inflammasomemaycontributetopathologicneovascularizationintheadvancedstagesofdiabeticretinopathy
AT bhavhparikh thenlrp3inflammasomemaycontributetopathologicneovascularizationintheadvancedstagesofdiabeticretinopathy
AT yeosiawey thenlrp3inflammasomemaycontributetopathologicneovascularizationintheadvancedstagesofdiabeticretinopathy
AT bobotun thenlrp3inflammasomemaycontributetopathologicneovascularizationintheadvancedstagesofdiabeticretinopathy
AT tienyinwong thenlrp3inflammasomemaycontributetopathologicneovascularizationintheadvancedstagesofdiabeticretinopathy
AT chidluu thenlrp3inflammasomemaycontributetopathologicneovascularizationintheadvancedstagesofdiabeticretinopathy
AT rupeshagrawal thenlrp3inflammasomemaycontributetopathologicneovascularizationintheadvancedstagesofdiabeticretinopathy
AT arkasubhraghosh thenlrp3inflammasomemaycontributetopathologicneovascularizationintheadvancedstagesofdiabeticretinopathy
AT alessandramortellaro thenlrp3inflammasomemaycontributetopathologicneovascularizationintheadvancedstagesofdiabeticretinopathy
AT elizabethrackoczy thenlrp3inflammasomemaycontributetopathologicneovascularizationintheadvancedstagesofdiabeticretinopathy
AT rajivrmohan thenlrp3inflammasomemaycontributetopathologicneovascularizationintheadvancedstagesofdiabeticretinopathy
AT veluchamyabarathi thenlrp3inflammasomemaycontributetopathologicneovascularizationintheadvancedstagesofdiabeticretinopathy
AT shyamschaurasia nlrp3inflammasomemaycontributetopathologicneovascularizationintheadvancedstagesofdiabeticretinopathy
AT raynerlim nlrp3inflammasomemaycontributetopathologicneovascularizationintheadvancedstagesofdiabeticretinopathy
AT bhavhparikh nlrp3inflammasomemaycontributetopathologicneovascularizationintheadvancedstagesofdiabeticretinopathy
AT yeosiawey nlrp3inflammasomemaycontributetopathologicneovascularizationintheadvancedstagesofdiabeticretinopathy
AT bobotun nlrp3inflammasomemaycontributetopathologicneovascularizationintheadvancedstagesofdiabeticretinopathy
AT tienyinwong nlrp3inflammasomemaycontributetopathologicneovascularizationintheadvancedstagesofdiabeticretinopathy
AT chidluu nlrp3inflammasomemaycontributetopathologicneovascularizationintheadvancedstagesofdiabeticretinopathy
AT rupeshagrawal nlrp3inflammasomemaycontributetopathologicneovascularizationintheadvancedstagesofdiabeticretinopathy
AT arkasubhraghosh nlrp3inflammasomemaycontributetopathologicneovascularizationintheadvancedstagesofdiabeticretinopathy
AT alessandramortellaro nlrp3inflammasomemaycontributetopathologicneovascularizationintheadvancedstagesofdiabeticretinopathy
AT elizabethrackoczy nlrp3inflammasomemaycontributetopathologicneovascularizationintheadvancedstagesofdiabeticretinopathy
AT rajivrmohan nlrp3inflammasomemaycontributetopathologicneovascularizationintheadvancedstagesofdiabeticretinopathy
AT veluchamyabarathi nlrp3inflammasomemaycontributetopathologicneovascularizationintheadvancedstagesofdiabeticretinopathy
_version_ 1724391595469438976